Quarterly Result22 Jul 2026, 02:41 pm
Jubilant Ingrevia Q1 FY27 Revenue Up 25% to ₹1,300 Cr
AI Summary
Jubilant Ingrevia reported a strong start to FY2027 with Q1 results showing a 25% year-on-year revenue growth to ₹1,300 crore and a 36% year-on-year increase in EBITDA to ₹209 crore. PAT grew by 41% YoY to ₹106 crore. The company highlighted resilient demand in the chemical industry, strong performance in Pharmaceuticals and Agrochemicals, and healthy growth in Nutrition and Personal Care. Specialty Chemicals business revenue grew 11% YoY. The company expects continued growth momentum driven by Specialty Chemicals and Nutrition, with a sequential improvement anticipated in the coming quarters. The new Multi-Purpose Plant is on track for commissioning by year-end.
Key Highlights
- Revenue grew 25% YoY to ₹1,300 crore in Q1 FY27.
- EBITDA increased 36% YoY to ₹209 crore, with margins at 16%.
- PAT surged 41% YoY to ₹106 crore.
- Specialty Chemicals revenue up 11% YoY, driven by Fine Chemicals and CDMO.
- New Multi-Purpose Plant to be commissioned by year-end.
Price Impact
More from JUBLINGREA